Targeting AAV vectors to the central nervous system by engineering capsid-receptor interactions that enable crossing of the blood-brain barrier.
Huang Q, Chen AT, Chan KY, Sorensen H, Barry AJ, Azari B, Zheng Q, Beddow T, Zhao B, Tobey IG, Moncada-Reid C, Eid FE, Walkey CJ, Ljungberg MC, Lagor WR, Heaney JD, Chan YA, Deverman BE
PLoS Biol. 2023 Jul 19;21(7):e3002112. doi: 10.1371/journal.pbio.3002112. eCollection 2023 Jul.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
ID | Plasmid | Purpose |
---|---|---|
203532 | iCAP-BI-28-KanR | RepCap for AAV production |
203533 | iCAP-BI-48-KanR | RepCap for AAV production |
203534 | iCAP-BI-49-KanR | RepCap for AAV production |
203535 | iCAP-BI-62-KanR | RepCap for AAV production |
203536 | iCAP-BI-65-KanR | RepCap for AAV production |